Cite
HARVARD Citation
Brannagan, T. et al. (2010). Alemtuzumab: the future of chronic inflammatory demyelinating polyradiculoneuropathy treatment?. Expert review of clinical immunology. pp. 319-321. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Brannagan, T. et al. (2010). Alemtuzumab: the future of chronic inflammatory demyelinating polyradiculoneuropathy treatment?. Expert review of clinical immunology. pp. 319-321. [Online].